WHO: World TB Day 2014: Reach the 3 million
19 March 2014 – “World TB Day, 24 March, is an opportunity to raise awareness about the burden of tuberculosis (TB) worldwide and the status of TB prevention and control efforts.
TB is curable, but current efforts to find, treat and cure everyone who gets ill with the disease are not sufficient. Of the 9 million people a year who get sick with TB, 3 million of them are “missed” by health systems. World TB Day provides the opportunity to call for further action to reach the 3 million. All partners can help take forward innovative approaches to ensure that everyone suffering from TB has access to TB diagnosis, treatment and cure…”
–       World TB Day 2014 brochure

Dartmouth and Aeras Join Forces to Conduct Study of New Tuberculosis Vaccine
New Product to Advance Findings from Trial of Related Vaccine
Excerpt
Hanover, NH and Rockville, MD, March 19, 2014 – Dartmouth’s Geisel School of Medicine and Aeras, a global nonprofit biotech, announced a collaboration to jointly conduct a trial of a new vaccine against tuberculosis. The vaccine, known as DAR-901, is related to the vaccine SRL-172, previously shown by Dartmouth investigators to decrease the risk of TB in a trial known as the DarDar Trial.

In the announcement today Aeras indicated that DAR-901 will now be added to Aeras’s portfolio of TB vaccines in clinical development. Dr. Tom Evans, Aeras President & CEO said, “The world desperately needs new vaccines to prevent the global spread of TB. We are pleased to join forces with Dartmouth’s Dr. Ford von Reyn and the DAR-901 partners in manufacturing the candidate and supporting the first clinical trial.”…